Company · cochlear-159f5241
Cochlear
4 sourcescompanies-2026-11-14-0.1.0
Cite this record
ConductScience Library. Cochlear. Companies, record cochlear-159f5241. Release companies-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/companies/cochlear-159f5241
On this page
Company
The name as ClinicalTrials.gov gives it. A company is a name ClinicalTrials.gov classes as industry, and spellings that differ only in case or spacing are one; no subsidiary is folded into a parent. A trial of two phases counts in both, and recruiting trials count as active.
- Name
- Cochlear
- Trials
- 110
- As lead sponsor
- 92
- As collaborator
- 18
- Recruiting
- 7
- Active, recruiting or not
- 22
- Completed
- 75
- Stopped early, withdrawn or suspended
- 11
- Posted results
- 56
- Trials by phase
- Phase 2 1
- Drugs its trials test
- 1
- Comparisons calculated in its trials
- 10
- First trial registered
- 1999-10-19
- Last update
- 2026-11-10
Source ClinicalTrials.gov
Pipeline1
The drugs its trials test, by the trial links the pipelines release's checks show. The phase is the highest phase those trials registered on ClinicalTrials.gov, not a development stage. Highest phase first, then the most trials.
| Drug | Highest phase registered | Trials | As lead sponsor | Recruiting | Targets | Mechanism | In Drugs and targets |
|---|---|---|---|---|---|---|---|
| DEXAMETHASONE | Not applicable | 1 | 1 | 0 | NR3C1 | Glucocorticoid receptor agonist | https://conductscience.org/library/drugs/CHEMBL384467 |
Source Open Targets
Trials110
The trials that name the company as lead sponsor or collaborator, newest registered first. Results posted are as ClinicalTrials.gov gave them on the day of the sponsors capture.
| Trial | Title | Role | Phase | Status | Type | Participants | Start | Results first posted | Drugs | In Trials | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT07893860 | Effect of a Totally Implantable Cochlear Implant on Tinnitus Severity in Adults With Preoperative Tinnitus | Lead sponsor | Not applicable | Not yet recruiting | Interventional | 14 | 2027-02 | https://conductscience.org/library/trials/NCT07893860 | ClinicalTrials.gov | ||
| NCT07763873 | A Study Examining Acceptability of Auditory Implant Fitting Software Technologies | Lead sponsor | Not applicable | Not yet recruiting | Interventional | 200 | 2026-10 | https://conductscience.org/library/trials/NCT07763873 | ClinicalTrials.gov | ||
| NCT07582198 | Hearing Outcomes With the Nucleus® 8 Sound Processor and Nucleus® 7 Sound Processor in Adult Veteran and Non-veteran Cochlear Implant Recipients | Lead sponsor | Not applicable | Completed | Interventional | 26 | 2026-05-20 | https://conductscience.org/library/trials/NCT07582198 | ClinicalTrials.gov | ||
| NCT07371299 | Correlations Between Subjective and Objective Responses to Cochlear Implant Stimulation | Collaborator | Not yet recruiting | Observational | 60 | 2026-01-15 | https://conductscience.org/library/trials/NCT07371299 | ClinicalTrials.gov | |||
| NCT07338864 | A Study to Evaluate Clinical Benefit, Performance and Safety of Cochlear Implants in Adults | Lead sponsor | Not yet recruiting | Observational | 66 | 2026-12 | https://conductscience.org/library/trials/NCT07338864 | ClinicalTrials.gov | |||
| NCT07287124 | A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults | Lead sponsor | Not applicable | Active, not recruiting | Interventional | 56 | 2026-04-03 | https://conductscience.org/library/trials/NCT07287124 | ClinicalTrials.gov | ||
| NCT07262827 | Investigating the Acceptance and Performance of Low Energy Audio Streaming in Nucleus 8 and Kanso 3 Sound Processors by Experienced Cochlear Implant Users | Lead sponsor | Not applicable | Recruiting | Interventional | 20 | 2026-03-12 | https://conductscience.org/library/trials/NCT07262827 | ClinicalTrials.gov | ||
| NCT07156461 | Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients | Lead sponsor | Not applicable | Completed | Interventional | 29 | 2025-09-09 | https://conductscience.org/library/trials/NCT07156461 | ClinicalTrials.gov | ||
| NCT07139327 | A Pivotal Study to Evaluate the Efficacy and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults | Lead sponsor | Not applicable | Active, not recruiting | Interventional | 36 | 2025-12-01 | https://conductscience.org/library/trials/NCT07139327 | ClinicalTrials.gov | ||
| NCT07130136 | Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients | Lead sponsor | Not applicable | Recruiting | Interventional | 20 | 2026-07-24 | https://conductscience.org/library/trials/NCT07130136 | ClinicalTrials.gov |
1 to 10 of 110
See all 110 trialsConditions57
The conditions its trials name, as the trials write them, with case and spacing folded. The most trials first.
| Condition | Trials |
|---|---|
| Hearing Loss | 41 |
| Sensorineural Hearing Loss | 10 |
| Hearing Loss, Sensorineural | 9 |
| Hearing Loss, Bilateral | 5 |
| Hearing Loss, Conductive | 5 |
| Conductive Hearing Loss | 4 |
| Hearing Impairment | 4 |
| Mixed Hearing Loss | 4 |
| Sensorineural Hearing Loss, Bilateral | 4 |
| Hearing Impairment, Sensorineural | 3 |
1 to 10 of 57Source ClinicalTrials.gov
See all 57 conditionsPartners53
The other organizations its trials name, as lead sponsor or collaborator, with the class ClinicalTrials.gov gives each. The most trials shared first. A partner that is a company opens its own record.
| Organization | Class | Trials shared | In Companies | Source |
|---|---|---|---|---|
| Avania | Industry | 13 | https://conductscience.org/library/companies/avania-8fe5acc9 | ClinicalTrials.gov |
| The Hearing Cooperative Research Centre | Other | 9 | ClinicalTrials.gov | |
| Royal Victoria Eye and Ear Hospital | Other government | 7 | ClinicalTrials.gov | |
| QbD Clinical | Industry | 4 | https://conductscience.org/library/companies/qbd-clinical-d558e795 | ClinicalTrials.gov |
| NAMSA | Other | 3 | ClinicalTrials.gov | |
| Statistiska Konsultgruppen | Other | 3 | ClinicalTrials.gov | |
| University of Iowa | Other | 3 | ClinicalTrials.gov | |
| Althea Anagnostopoulos Harrington | Unknown | 2 | ClinicalTrials.gov | |
| LWB Consulting | Unknown | 2 | ClinicalTrials.gov | |
| MV Clinical Research, LLC | Unknown | 2 | ClinicalTrials.gov |
1 to 10 of 53
See all 53 partnersData dates
The date of each source this release read.
Sources 4
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL
- ClinicalTrials.govNo license stated
- Open TargetsCC0 1.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBLCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this company from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/companies/v1/cochlear-159f5241
GET https://conductscience.org/api/companies/v1/cochlear-159f5241/trials?page=2